Delivery Order SPE2DB24D2018-SPE2DB25FWWU1
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with DLA. The award carries no set-aside designation and will be performed at the vendor's corporate office...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for M-M-R II vaccine vials valued at $4,069.61 with a firm fixed price structure. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, and was not designated as a set-aside contract. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 15, 2025, for M-M-R II vaccine vials valued at $23,094.80. This firm fixed price delivery order, which carries an ultimate completion date of July 16, 2025, is unset-aside and represents a competitive award under AmerisourceBergen's existing federal contract vehicle. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for M-M-R II vaccine vials valued at $3,269.25 on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under a competitively awarded, non-set-aside procurement by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. The contract represents...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $15,679.50 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for MMR II vaccine vials valued at $3,776.61. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, PA. The award carries no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for M-M-R II vaccine vials with a ceiling value of $2,330.79. This firm fixed-price delivery order, which is not associated with any set-aside designation, is expected to be completed by August 12, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a routine...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,561.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of M-M-R II vaccine vials, with an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
- The Defense Logistics Agency awarded a $11,085.83 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting open competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This award...
- The Defense Logistics Agency awarded a $7,390.48 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWU1Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $2,882.55 for M-M-R II vaccine vials. The contract was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, under a firm fixed-price arrangement with no set-aside designation. The delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This delivery order represents a discrete fulfillment action within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency. The company serves as a critical vendor for federal military medical procurement, supplying a broad range of pharmaceutical products and medical supplies to support Department of Defense healthcare programs. The DLA, operating under the Department of Defense, utilizes such contracts to ensure consistent access to essential vaccines and medical commodities across military healthcare systems. AmerisourceBergen's demonstrated capability to fulfill this order reflects its established role as a major pharmaceutical distributor capable of meeting federal procurement requirements through competitive, open-market selection processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/17/25 |